Eli Lilly and Company & GSK plc
7 shared events · Importance 3 · Last updated Jul 02, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Eli Lilly and Company: Eli Lilly and Company is a leading pharmaceutical company with strong balance sheets, enabling it to be a major acquirer in the current M&A wave. It is also facing patent expirations on some of its blockbuster drugs.
GSK plc: GSK plc has adopted a more aggressive M&A approach following recent CEO transitions, contributing to the overall increase in dealmaking.
May 01, 2026 · 6 articles
Tech
Eli Lilly and Company: Eli Lilly and Company>>> produces GLP-1 drugs like Zepbound, Mounjaro, and Trulicity, which are showing potential benefits in cancer prevention and treatment.
GSK plc: GSK plc>>>'s drug Avodart is mentioned in a comparison study where GLP-1s were associated with lower rates of prostate cancer diagnoses.
Jun 02, 2026 · 45 articles
Business
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
GSK plc: GSK plc>>> agreed to acquire GSK plc>>> for $10.6 billion, marking its largest deal in years and expanding its presence in cancer drug development.
May 20, 2026 · 72 articles
Tech
Eli Lilly and Company: Eli Lilly is a consortium member. The study's results could support its use of multimodal home-based assessments in CNS trials.
GSK plc: GSK is a consortium member. The publication may inform its clinical development programs in ALS and FTD.
Aug 18, 2026 · 6 articles
Business
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
GSK plc: Soared 39% after GSK agreed to buy it for $10.6 billion.
Apr 20, 2026 · 344 articles
Business
Eli Lilly and Company: Eli Lilly has a strategic collaboration with Scribe, which may benefit from Scribe's successful IPO and pipeline progress.
GSK plc: GSK plc's acquisition of Nuvalent Inc. is another example of big pharma M&A that supports biotech valuations.
Jul 06, 2026 · 25 articles
Regulatory
GSK plc: GSK plc is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Eli Lilly and Company and GSK plc interact across events, view sentiment trends, and discover connected entities.
Open Dashboard